Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Small Intestinal And Faecal Microbiota Of Adult Celiac Patients And First-Degree Relatives.

PROVIDER: PRJNA385740 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5514930.fastq.gz	Fastqsanger.gz
	SRR5514930_1.fastq.gz	Fastqsanger.gz
	SRR5514930_2.fastq.gz	Fastqsanger.gz
	SRR5514940_1.fastq.gz	Fastqsanger.gz
	SRR5514940_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 207

Similar Datasets

human gut metagenome

Project description:Small Intestinal And Faecal Microbiota Of Adult Celiac Patients And First-Degree Relatives.

| PRJNA385735 | ENA

First Degree Relatives (FDRs) of Patients with Celiac Disease Harbour an Intestinal Transcriptomic Signature that Might Protect Them from Enterocyte Damage

Project description:Patients with Celiac Disease, first degree relatives of celiac patients and control groups displayed significant differential gene expression.

2019-03-21 | GSE112102 | GEO

Species-level resolution of the gut microbiota in celiac disease

Project description:Kinship perspective study on subjects with celiac disease with first-degree non-celiac relatives.

| PRJEB74092 | ENA

Gut microbiome of celiac disease patients

Project description:Composition and functional variation in gut microbiome of celiac disease patients and first-degree relatives

| PRJEB5780 | ENA

First Degree Relatives (FDRs) of Patients with Celiac Disease Harbour an Intestinal Transcriptomic Signature that Might Protect Them from Enterocyte Damage

Project description:First Degree Relatives (FDRs) of Patients with Celiac Disease Harbour an Intestinal Transcriptomic Signature that Might Protect Them from Enterocyte Damage

| PRJNA439287 | ENA

Analysis of small ncRNAs in stool samples from ASD patients

Project description:Intestinal microorganisms impact on health maintaining gut homeostasis and shaping the host immunity, while gut dysbiosis associates with many conditions including autism, a complex neurodevelopmental disorder with multifactorial aetiology. In autism, gut dysbiosis correlates with symptom severity and is characterized by a reduced bacterial variability and a diminished beneficial commensal relationship. Microbiota can influence the expression of host microRNAs that, in turn, regulate the growth of intestinal bacteria by means of bidirectional host-gut micro-biota cross-talk. We investigated possible interactions among intestinal microbes and between them and host transcriptional modulators in autism. To this purpose, we analysed, by “omics” technologies, faecal microbiome, mycobiome and small non-coding-RNAs (particularly miRNAs and piRNAs) of children with autism and neurotypical development. Patients displayed gut dysbiosis, related to a reduction of healthy gut micro- and mycobiota, and up-regulated tran-scriptional modulators. The targets of dysregulated non-coding-RNAs are involved in intestinal permeability, inflammation and autism. Furthermore, microbial families, underrepresented in patients, participate to the production of human essential metabolites negatively influencing the health condition. Here, we propose a novel approach to analyse faeces as a whole and, for the first time, we detected miRNAs and piRNAs in faecal samples of patients with autism.

2022-03-12 | GSE198199 | GEO

Intestinal Microbiota Composition is Predictive of Radiotherapy-induced Acute Gastrointestinal Toxicity in Prostate Cancer Patients

Project description:The search for factors beyond the radiotherapy dose that could identify patients more at risk of developing radio-induced toxicity is essential to establish personalised treatment protocols for improving the quality-of-life of survivors. To investigate the role of the intestinal microbiota in the development of radiotherapy-induced gastrointestinal toxicity, the MicroLearner observational cohort study characterised the intestinal microbiota of 136 (discovery) and 79 (validation) consecutive prostate cancer patients at baseline radiotherapy. Gastrointestinal toxicity was assessed weekly during RT using CTCAE. An average grade >1.3 over time points was used to identify patients suffering from persistent acute toxicity (endpoint). The intestinal microbiota of patients was quantified from the baseline faecal samples using 16S rRNA gene sequencing technology.

2024-07-25 | GSE268869 | GEO

Immunoglobulin V-gene usage among human serum IgA with or without specificity to the autoantigen transglutaminase 2

Project description:To study V-gene usage among antigen-specific and non-antigen-specific serum IgA antibodies in celiac disease patients, purified antibody fractions were subjected to proteomic analysis. Patients either had eastablished, untreated disease with severe intestinal inflammation or "potential" celiac disease characterized by presence of antibodies but no or mild inflammation. Quantification of the fraction of antibodies using different IGHV segments revealed that antibodies specific to the autoantigen transglutaminase 2 (TG2) displayed a bias toward usage of IGHV5-51 in agreement with previous observations. The fraction of antibodies using IGHV5-51 correlated with the degree of intestinal inflammation, indicating that production of hallmark IGHV5-51 anti-TG2 antibodies coincides with onset of clinical celiac disease.

2019-07-09 | PXD013777 | Pride

Deciphering the gut microbiota of very early systemic sclerosis (VEDOSS): the first taxonomic and functional characterization

Project description:Comparison of the faecal microbiota in patients with very early SSc (VEDOSS) and established SSc (systemic sclerosis).

2024-11-27 | GSE261579 | GEO

Project description:Gut microbiota composition in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives

| PRJEB38765 | ENA